Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement for novel oral agent to treat Type II Diabetes
Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data at the IDF's 20TH World Diabetes Congress
Shire Targets Fourth Quarter Filing of BLA for REPLAGAL
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom
ConjuChem Announces Fiscal 2009 Third Quarter Financial Results
Norgine acquires cetilistat
Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor
Clients in focus...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd All rights reserved. Terms and Conditions | Contact us